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INTRODUCTION
In free energy calculations of a binding reaction, a thermodynamic
cycle (e.g., as shown in Fig. 1) is typically used to relate the calculated
properties of the free ligand, the free target, and the ligand-target
complex in solution to account for the observed binding affinity. Gen-
erally, only the binding reaction itself is considered. Other equilibria,
such as acid-base equilibria where for example the ligand and/or
enzyme may exist in various ionized forms or protonation states at a
given pH are ignored. In such cases the influence of acid dissociation
constants (pKa) and also ionic strength, which may affect the apparent
pKas, must also be considered.1,2
In this work we present free energy calculations of ligand-target
binding reactions where the ionization equilibria of the ligands in so-
lution are taken into account. These apply to the general case of vari-
ous species of a ligand in solution related by pKa equilibria where
only one such species binds to the target molecule. Quantification of
the contribution to the free energy of binding from the ionization
equilibria of the ligands is particularly important in view of the fact
that experimental estimates of binding affinities—based on the total
ligand concentration—involve all equilibria of the ligands (and target)
in solution. Whereas calculated affinities are generally based on the
form of the inhibitor that binds the enzyme and consider only the
binding equilibria. As a consequence one cannot directly compare ex-
perimental and calculated binding affinities unless one accounts for
the contribution from the other equilibria in solution.
As an example we consider the binding of 2-phosphoglycolate
(PGA) and 3-phosphonopropionate (3PP) to the glycolytic enzyme
triosephosphate isomerase (TIM).3,4 These two inhibitors bind to
TIM in a specific protonation state (species C in Fig. 2) that differs
from the main protonation state observed in water solution at pH 7.
Moreover, the protonation state of the inhibitors change upon bind-
ing: they are fully deprotonated once they are in the active site of the
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ABSTRACT
When estimating binding affinities of a ligand,
which can exists in multiple forms, for a target
molecule, one must consider all possible com-
peting equilibria. Here, a method is presented
that estimates the contribution of the protona-
tion equilibria of a ligand in solution to the
measured or calculated binding affinity. The
method yields a correction to binding con-
stants that are based on the total concentration
of inhibitor (the sum of all ionized forms of
the inhibitor in solution) to account for the
complexed form of the inhibitor only. The
method is applied to the calculation of the dif-
ference in binding affinity of two inhibitors, 2-
phosphoglycolate (PGA) and its phoshonate
analog 3-phosphonopropionate (3PP), for the
glycolytic enzyme triosephosphate isomerase.
Both inhibitors have three titrating sites and
exist in solution as a mixture of different
forms. In this case the form that actually binds
to the enzyme is present at relative low con-
centrations. The contributions of the alterna-
tive forms to the difference in binding energies
is estimated by means of molecular dynamics
simulations and corrections. The inhibitors
undergo a pKa shift upon binding that is esti-
mated by ab initio calculations. An interesting
finding is that the affinity difference of the two
inhibitors is not due to different interactions
in the active site of the enzyme, but rather due
to the difference in the solvation properties of
the inhibitors.
Proteins 2009; 76:138–150.
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enzyme (species F in Fig. 2).5,6 Here, we show that if the
pKas of the inhibitors are known it is possible to correct
for these effects. The difference in affinity of the bound
species of the inhibitors to the enzyme can then be esti-
mated using standard molecular dynamics (MD) simula-
tion methods. It is possible to directly compare calculated
and experimental estimates of the binding affinities, only
when all mentioned contribution are considered. The cal-
culated affinity will be discussed together with the avail-
able experimental results.7,8
Figure 1
Thermodynamic cycle for the binding of TIM to 2-phosphoglycolate (DG1a 1 DG1b) and 3-phosphonoproprionate (DG2a 1 DG2b). PGA/3PP and
PGA-H/3PP-H indicate the bound and binding form of the inhibitors, species F and specie C in Figure 2, respectively. The binding reaction is
described in two steps. First a proton is abstracted from PGA-H and 3PP-H in solution (DG1a and DG2a for PGA and 3PP, respectively). At the
same time the catalytic Glu of TIM is protonated resulting in TIM-H. In the second step (DG1b and DG2b for PGA and 3PP, respectively), the
binding of PGA and 3PP to TIM is described. Because of the thermodynamic cycle, the difference DG1b 2 DG2b must equal to DG3 2 DG4, where
DG3 and DG4 are the free energy differences for the mutation of PGA into 3PP in solvent and in the active site of the enzyme, respectively. DG1a, D
G2a, DG3, and DG4 were calculated as described in the Methods and are reported in kJ mol
21. Note that the values of DG1a and DG2a do not
include the contribution from the TIM ? TIM-H reaction.
Figure 2
Protonation equilibria of PGA and 3PP in solution. The two inhibitors differ for the presence of a phosphate (PGA) or phosphonomethyl (3PP)
moiety (indicated as O;CH2, respectively). The inhibitors have one protonation site on the carboxylic group and two on the phosphate/
phosphonomethyl groups. To a first approximation the two latter are indistinguishable. Consequently, only six species (instead of eight) are
considered. Estimated concentrations are reported in square parenthesis (the first and second percentage refer to PGA and 3PP, respectively). pKaI,
pKaII, and pKaIII are the experimental pKas and were associated with reactions A?B, B?E (pK1), and E?F (pK4), respectively. pK2 (C?F) and
pK3 (B?C) were estimated as described in the Methods. Reactions between compounds B, C, E, and F are indicated with numbers for easy
reference with the text. Species C and F are the binding and bound form of the inhibitors, respectively.
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METHODS
The form of the inhibitors PGA and 3PP that binds to
TIM (species C in Fig. 2) is different from the bound
form (species F in Fig. 2), and is also not the dominant
state of the inhibitors in water solution, as mentioned in
the Introduction. Thus, while the relative free energy of
binding can be computed for the fully deprotonated
form F, the experimentally determined affinity contains
contributions from all accessible protonation states of the
ligand and the protein. Consequently, to be able to com-
pare an experimental and computed relative affinity, two
additional corrections are required to the values obtained
by standard MD free energy calculations:
1. The experimentally measured affinity must be cor-
rected to account for the fact that only species C
binds. This step results in the effective free energy of
binding of species C (see Effective affinity section).
2. The computed affinity for species F must be corrected
for the free energy that is required to transfer a pro-
ton to species F. This step results in the predicted free
energy of binding of species C (see Predicted relative
affinity section).
Note that the different protonation states of the
enzyme are not included. We expect that these are not
contributing to the affinity difference of the two inhibi-
tors for the enzyme TIM. In particular, as we consider
the binding of two inhibitors to the same enzyme, any
contribution from the free enzyme protonation equilibria
to the affinity would be very similar for the binding of
PGA and 3PP, and would therefore cancel when consider-
ing the difference in affinities. There is no evidence that
the protonation state of the enzyme is different in the
two inhibitor-enzyme complexes and we assume that dif-
ferences in these complexes are all accounted for in the
free energy calculations. See the Discussion for more
details.
Effective affinities
The experimentally determined equilibrium association
constants Ka(exp) for the binding of the inhibitors PGA
and 3PP to TIM (Table I) can be expressed as:
KaðexpÞ ¼ ½TIM  C½TIM½I ð1Þ
where [I] represents the total concentration of all forms
of inhibitor in solution and C denotes the specific form
of the inhibitor that binds to the enzyme TIM (Fig. 2).
The effective affinity is defined as the affinity of the form
C of the inhibitor for TIM. The effective association
constant, Ka(eff), is related to Ka(exp) by the following
relation:
KaðeffÞ ¼ ½TIM  C½TIM½C
KaðeffÞ ¼ ½TIM  C½TIM½I
½I
½C
KaðeffÞ ¼ KaðexpÞ ½I½C
ð2Þ
where [C] is the equilibrium concentration of C free in
solution. Equation (2) can be expressed in terms of effec-
tive binding free energy DG(eff):
DGðeffÞ ¼ RT lnKaðeffÞ
DGðeffÞ ¼ DGðexpÞ  RT ln ½I½C
ð3Þ
The difference in the effective binding free energy
DDG(eff) of the two ligands PGA and 3PP can therefore
be written as:
DDGðeffÞ ¼ DGðeffÞPGA  DGðeffÞ3PP
DDGðeffÞ ¼ DGðexpÞPGA  DGðexpÞ3PP









where CPGA and C3PP are the C species of the inhibitors
PGA and 3PP, respectively, and [IPGA] and [I3PP] are the
total equilibrium concentrations of inhibitors PGA and
3PP, respectively, in solution.
DDG(eff) in Eq. (4) is the difference in the free energy
of binding of species C of PGA and 3PP for TIM, which
Table I
Experimental7,8 (exp) and Theoretical Results for the Affinity of PGA
and 3PP to TIM
exp exp eff
Ki,PGA 0.027  0.005 DGPGA 226.1  0.4 240.7
Ki,3PP 27 DG3PP 29.0 215.5
DGPGA 2 DG3PP 217.1 225.2
Ki,DHAP 0.66  0.06 DGDHAP 218.2  0.2
Ki,DGAP 0.008  0.002 DGDGAP 229.1  0.7
2.303RT (pK1a,2a,(1a-2a)) MD 1 TI
DG1a 29.1 DG3 28.3  4.3
DG2a 39.4 DG4 24.1  7.2
DG1a 2 DG2a 210.3 DG3 2 DG4 5 DDG (calc) 4.2  8.4
DDG (pred) 5 DG1a 2 DG2a 1 DDG (calc) 5 26.1
Binding affinities of dihydroxyacetone phosphate (DHAP) and D-glyceraldehyde
3-phosphate (DGAP) are also reported.7 DG(exp) is obtained as DG 5 RTlnKi,
with Ki the experimental inhibition constant, R the gas constant, and T the tem-
perature (298 K). DG(eff) (effective) of PGA and 3PP are derived from the experi-
mental ones as described in the Methods. Free energy differences DG in the lower
panel are labeled according to Figure 1. pK1a and pK2a are listed in Figure 2 and
are calculated as described in the Methods. Ki in mM, DG in kJ mol
21.
MD, molecular dynamics; TI, thermodynamic integration.
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can be compared with the predicted relative binding free
energy DDG(pred) [Eqs. (14) and (17)]. DDG(eff) corre-
sponds to the first correction mentioned at the beginning
of the Methods section. It remains now to estimate the
equilibrium concentrations of C and I.
Determination of equilibrium
concentrations
The equilibrium concentrations of the different species
in solution can be calculated using the following equa-
tions:
½I0 ¼ ½I þ ½TIM  C ð5Þ
½TIM0 ¼ ½TIM þ ½TIM  C ð6Þ
Here, [I]0 and [TIM]0 represent the initial concentra-
tions of inhibitor (I) and enzyme (TIM), respectively,
and TIMC is the complex between the inhibitor and
TIM.
Combining Eqs. (1) and (6) gives:
½TIM0 ¼
½TIM  C
KaðexpÞ½I þ ½TIM  C ð7Þ
The inhibitor I exists in solution in different ioniza-
tion species (Fig. 2) and [I] can be written as the
sum of the concentrations of all different species in
solution:
½I ¼ ½A þ ½B þ ½C þ ½D þ ½E þ ½F ð8Þ
On the basis of the experimentally determined acid
dissociation constants (pKas) of PGA and 3PP it is esti-
mated that at pH 7.6 species A and D are present in neg-
ligible concentration (as is explained in the Results), and
for simplicity in the following we consider [A] 5 [D] 5
0. If Eq. (8) is now expressed as a function of [C], the




þ ½C þ K2½C
K4
þ K2½C½Hþ ð9Þ
where K2, K3, and K4 are associated with the proton dis-
sociation reactions C?F, B?C, and E?F (Fig. 2),
respectively, and are obtained from the corresponding
calculated pK or experimental pKa values. The proton
concentration [H1] is calculated from the pH of the so-
lution at which the experiment was carried out (7.6).7
When [I] in Eqs. (5) and (7) is expressed as in Eq.





þ ½C þ K2½C
K4





þ ½C þ K2½C
K4
þ K2½C½Hþ
þ ½TIM  C ð11Þ
The program Mathematica9 was used to solve such a
system, with [I]0 5 [TIM]0 5 1 M and Ki(exp) the ex-
perimental inhibition constant (1/Ka(exp)) in Table I.
The equilibrium concentrations of the other species can
then also be calculated with Eq. (9). [C] and [I] ([I]0-
[TIMC]) are now determined and are used to estimate
the difference in the effective binding free energy
DDG(eff) in Eq. (4).
Predicted relative affinity
The form of the inhibitors that bind to TIM (species
C in Fig. 2) carries a negative charge of 22e on the
phosphate and phosphonomethyl moiety of PGA and
3PP, respectively, just as the natural substrates of the
enzyme: dihydroxyacetone phosphate (DHAP) and D-
glyceraldehyde 3-phosphate (DGAP).10,11 In the first
step of the isomerization catalyzed by TIM, a proton is
abstracted by the catalytic glutamic acid (Glu) in the
active site of the enzyme from the substrate’s hydroxylic
carbon.3,4,12 Accordingly, upon binding, the carboxylate
proton of PGA and 3PP is donated to the catalytic Glu
of TIM (this form of TIM is denoted as TIM-H). Conse-
quently, the inhibitors are fully deprotonated in the
active site of the enzyme (carrying an overall charge of
23e, species F in Fig. 2).5,6
Figure 1 details the thermodynamic cycle that is
employed to estimate the difference in the free energy of
binding DDG(pred) (predicted relative affinity) between
species C of PGA and 3PP for TIM. As shown in Figure
1, the binding reaction is divided in two steps: (a) species
C of the inhibitor donates a proton to the solution,
resulting in species F, and the catalytic Glu of TIM takes
up a proton from the solution, resulting in TIM-H; (b)
species F binds TIM-H. The deprotonation of the inhibi-
tor/protonation of TIM and the binding reaction are
therefore described by two different reactions. DG1 and
DG2, the affinities of species C of PGA and 3PP for TIM,
respectively, are consequently obtained as:
DG1 ¼ DG1a þ DG1b ð12Þ
DG2 ¼ DG2a þ DG2b ð13Þ
DDG(pred) can now be calculated as:
DDG predð Þ ¼ DG1  DG2
DDG predð Þ ¼ DG1a  DG2a þ DG1b  DG2b
ð14Þ
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The difference in (de)protonation free energies DG1a 2
DG2a in Eq. (14) can be obtained from:
DG1a  DG2a ¼ 2:303RTðpK1a  pK2aÞ ð15Þ
where pK1a and pK2a are the pKs relative to the deproto-
nation of the carboxylic groups of the binding form of
PGA and 3PP, respectively, in solution to yield the fully
charged 23e inhibitors. The method used to calculate
these pKs is explained in the ‘‘pK calculations’’ section
below. DG1a 2 DG2a is the correction to the computed
relative affinity to account for the transfer of the proton
to species F. TIM is protonated (TIM?TIM-H in Fig. 1)
in both processes DG1a and DG2a. Because the enzyme is
in this step of the thermodynamic cycle free in solution,
the protonation reactions occur independently of the in-
hibitor. Therefore, they contribute equally to DG1a and
DG2a and do not make a net contribution to the differ-
ence in these two free energies.
From the thermodynamic cycle (Fig. 1), the difference
DG1b 2 DG2b can be obtained as:
DG1b  DG2b ¼ DG3  DG4 ð16Þ
where DG3 and DG4 are the free energies of mutating
species F of PGA into 3PP in solution and in the active
site of the enzyme, respectively. DG3 and DG4 can be
computed via thermodynamic integration and molecular
dynamics simulation techniques (described in the follow-
ing two sections). Note that DG3 2 DG4 is the relative
affinity of species F for TIM which we refer to as
DDG(calc)
Equation (14) now becomes:
DDG predð Þ ¼ DG1a  DG2a þ DG3  DG4
DDG predð Þ ¼ DG1a  DG2a þ DDGðcalcÞ
ð17Þ
Thermodynamic integration
The free energy difference between two states A and B was










Here k is a coupling parameter and H is the (classical)
Hamiltonian of the system. <qH/qk> was estimated as the
average qH/qk during an equilibrium molecular dynamics
(MD) simulation with k kept constant. A total of 18 inde-
pendent simulations were performed with different k values
between 0 and 1 to model the transformation of PGA into
3PP in water and in the active site of the protein. For every k
point, 100 ps of equilibration was followed by 200 ps of data
collection. Reverse transformations were also carried out
using the resulting structure at k5 1 as the starting configu-
ration. The simulations are described in detail in the follow-
ing section.
The transformation was achieved by the mutation of
an oxygen atom into a carbon atom with all associated
bonded and nonbonded interactions being mutated
accordingly (the parameters used are reported in Table II
and Fig. 3). For this a dual topology approach was
applied. A molecule was constructed containing the two
COO2 groups of PGA and 3PP. During the transforma-
tion, the interactions of the COO2 atoms of PGA with
the rest of the system were gradually reduced to zero,
whereas the interactions of the COO2 atoms of 3PP
were gradually increased. The mass of the atoms was
held constant and the COO2 groups of PGA and 3PP
did not interact with each other. Only PGA of subunit A
of TIM was mutated into 3PP.
The numerical integration of Eq. (18) was carried out
using the trapezoidal method. The error in the hqH/qki
was calculated using a block averaging procedure.13,14
Nonbonded interactions between the initial and the final
Table II










C-CH2a-Op4/CH2b 0.143 8.18e106 0.153 7.15e106














Proper dihedrals F0 (8)
kF (kJ
mol21) n F0 (8)
kF (kJ
mol21) n
Od1-C-CH2a-Op4/CH2b 180.0 4.305 2 0.0 3.502 2
C-CH2a-Op4/CH2b-P 0.0 3.77 3 0.0 5.86 3
CH2a-Op4/CH2b-P-Op1 0.0 1.05 3 0.0 2.93 3






For 3PP, only the parameters that differ from PGA are reported explicitly. Atoms
labeled according to Figure 3.
aBonded potential energy functions:
Bond potential: Vb(b) 5 ¼ k
b (b2 2 b0
2)2;
Angle potential: Va(y) 5 ½ k
y (cosy 2 cosy0)
2;
Proper dihedral potential: Vd(F) 5 k
F (11cos(nF 2 F0));
Improper dihedral potential: Vid(e) 5 ½ k
e (e 2 e0)
2.
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state were interpolated using a soft-core potential15 as
implemented in the GROMACS package.16 The soft-core
parameter alpha was set to 1.51.
Molecular dynamics simulations
The GROMOS96 force field 43a117 was used to
describe the system. Aliphatic hydrogen atoms were
treated as united atoms, together with the carbon atom
to which they were attached. Force field parameters
(charges and Lennard-Jones parameters) of the phosphate
and phosphonomethyl group of the inhibitors were
derived from the force field parameters of phosphoser-
ine.18,19 Quantum mechanical calculations, performed
with the Gaussian03 program,20 were used to determine
the minimum energy conformations of the inhibitors in
vacuum at the RHF/6-31G* level of theory. The torsion
around the CH2aC bond (Fig. 3) was parametrized
using the results from the ab initio calculations and the
X-ray structures of the free inhibitors.21,22 1-4 Lennard-
Jones interactions involving the mutated atom (O?C)
and carboxylic oxygens were excluded. The partial atomic
charges and the bonded parameters are reported in Table
II and Figure 3.
All molecular dynamics simulations were performed
with the GROMACS suite of programs.16,23,24 The
starting structure of the inhibitor-enzyme complex was
the RCSB-PDB25 atomic resolution (0.83 A˚) X-ray struc-
ture of liganded TIM (PDB code 1N55).26 The free
inhibitor was placed in a cubic box and the inhibitor-
enzyme complex (and 542 crystallographic water mole-
cules per monomer) in a dodecahedral box which were
subsequently filled with 1509 and 18,718 SPC (Simple
Point Charge) water molecules,27 respectively. A twin
range cut-off was used for the Coulomb and Lennard-
Jones interactions. Interactions between atoms within 0.9
nm were evaluated every step, while interactions between
atoms lying between 0.9 and 1.4 nm were evaluated every
5 steps. To correct for the neglect of electrostatic interac-
tions beyond the long range cutoff (1.4 nm), a reaction
field (RF) correction with eRF 5 78.0 was employed.
Constant pressure and temperature were maintained by
weakly coupling the system to an external bath at 1 bar
and 298 K using the Berendsen barostat and thermo-
stat28 with coupling times of 1.0 and 0.1 ps, respectively.
A leap-frog integrator was used.29 The integration time
step was 2 fs. The bond distances and the bond angle of
water were constrained using the SETTLE algorithm.30
All other bond distances were constrained using the
LINCS algorithm.31 Before the simulations, the potential
energy of each system was minimized using a steepest
descent approach, followed by a 20 ps molecular dynamics
(MD) simulation with position restraints (force constant
equal to 1000 kJ mol21 nm22) on the inhibitor and
enzyme to relax the waters. A 200 ps simulation was per-
formed to equilibrate each system before initiating the free
energy calculations. In all calculations, position restraints
were applied on all heavy atoms of the enzyme using a har-
monic force constant of 1000 kJ mol21 nm 22.
pK calculations
Theoretical estimates of pKs were obtained from the
standard free energies of deprotonation as computed
Figure 3
Schematic representation of PGA and 3PP in the fully deprotonated form (23e). Atomic charges (e) are indicated in the upper left corner of each
atom. The atom and charges that differ between PGA and 3PP are indicated in bold. For comparison Mulliken charges are also listed.
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with the Liptak and Shields approach32 using the pro-
gram Gaussian03.20 The free energy of a proton dissocia-
tion reaction was estimated in vacuum, and the differ-
ence between the solvation free energies of the reactants
and products was then added. The B3LYP/6-31G* level
of theory was applied in all computations. The geometry
of each species was optimized in vacuum and the energy
estimated. To correct for changes in vibrational entropy,
a frequency calculation was performed with Gaussian03.
To estimate the free energy of solvation of each species,
the polarizable continuum model (PCM)33,34 was
applied.
pKs were calculated for the following deprotonation
reactions of PGA and 3PP in solution: B?E, B?C,
C?F, and E?F (pK1, pK3, pK2, and pK4 in Fig. 2,
respectively) as described in the previous paragraph. The
pK2s of reactions C?F of PGA and 3PP correspond to
pK1a and pK2a, respectively [Eq. (15)] and are required
to calculate the difference DG1a 2 DG2a (Fig. 1). A num-
ber of experimental pKa values for the free inhibitors in
solution are available (Table III) and were assigned to the
reactions A?B, B?E, and E?F (indicated as pKaI,
pKaII, and pKaIII, respectively, in Fig. 2). This assignment
is discussed in detail in the Results section.
As the calculations of absolute pKs are prone to very
large systematic errors, the shift in the pKs for reactions
C?F (pK2) with respect to B?E (pK1), DpK221, and
B?C (pK3) with respect to E?F (pK4), DpK324, were
used in preference to the raw values obtained from the
calculations. DpK221 and DpK324 can be interpreted as
the shifts in the pK of a certain protonation equilibria
when the overall charge on the molecule changes (Fig.
2). pK2 and pK3 were then obtained by combining the
experimentally measured pKa values with the calculated
pK shifts:
pK2 ¼ pKaII þ DpK21 ð19Þ
pK3 ¼ pKaIII þ DpK34 ð20Þ
RESULTS
The difference in the free energy of binding (DDG) or
relative binding affinity of the two inhibitors PGA and
3PP for the enzyme TIM was calculated. Both inhibitors
contain three titrating sites and in solution they exist as
a mixture of alternatively protonated forms of which
only species C (Fig. 2) binds to TIM. In a solution of the
enzyme and inhibitor, therefore, both the binding equi-
librium between inhibitor and enzyme and ionization
equilibria of the inhibitor (and enzyme) will occur. The
experimental affinity DG(exp) is obtained from the total
inhibitor concentration, which is the sum of all forms of
inhibitor in solution. This implies that all ionization
equilibria of the inhibitors in solution contribute to
DG(exp). This work determines the magnitude of this
contribution. Note that the ionization equilibria of the
enzyme which may also contribute to the binding prop-
erties were not included. The computationally obtained
estimates of relative binding affinity DDG(pred) typically
consider only the binding species itself, species C in this
particular case, such that any contribution to the affinity
from other equilibria are neglected. Consequently,
DDG(pred) and DDG(exp) cannot be compared directly.
To correct for the difference between DDG(exp) and
DDG(pred) one must determine the contribution of the
ionization equilibria to the experimental affinity and sub-
tract this from DDG(exp), the result of which is referred
to as DDG(eff) (effective) because it is a measure of the
(effective) affinity of the binding form C of the inhibitor
for TIM, without contributions from the other equilibria
in solution. DDG(eff) can be estimated if the ratio of the
equilibrium concentrations of the binding form (in this
case species C) of the inhibitor and the total inhibitor I
in solution are known [Eq. (4) in the Methods]. The rel-
ative concentrations of the different species can in turn
be obtained from the pKas of the ionizable groups [see
Eqs. (5) – (9) in the Methods section].
The binding species C of PGA and 3PP correspond to
only 0.27 and 7.2% of the total concentration of the
inhibitors (Fig. 2). Given that the DDG(exp) is 217.1 kJ
mol21 (Table I ), we obtain from Eq. (4) in kJ mol21:
DDGðeffÞ ¼ DDGðexpÞ  8:1 ¼ 25:2 ð21Þ
That is the true affinity difference of species C, DDG
(eff), is about 8 kJ mol21 more negative than the experi-
mental value which include all the nonbinding forms.
In other words, PGA has effectively an 28.1 kJ mol21
higher affinity for TIM with respect to 3PP than experi-
mentally measured. This is a consequence of the fact that
at pH 7.6, the pH at which the affinity measurements
were performed,7,8 the concentration of the binding
form of PGA was much lower than that of 3PP.
Having accounted for the contribution of the ioniza-
tion equilibria of the inhibitors in solution to the bind-
ing affinity, it is now possible to relate the calculated
binding affinity, DDG(pred), to the experimental value,
using the thermodynamic cycle in Figure 1 where only
the binding of the C form of the inhibitors is considered.
Table III
Experimentally Determined pKa Values of PGA10 and 3PP35 in
Solution
Ligand pKa I pKa II pKa III
PGA <2 3.6 6.8
3PP 2.26  0.04 4.63  0.02 7.75  0.02
S. Donnini et al.
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As can be seen in Figure 1, the binding reaction has
been divided into two steps. The inhibitors are first
deprotonated while in solution and then allowed to bind
to the enzyme. In Figure 1, 3PP-H/PGA-H indicates the
binding form of the inhibitors (species C in Fig. 2) and
PGA/3PP the bound form (species F in Fig. 2). The rela-
tive free energy of binding of the bound form F of the
inhibitors (DG1b 2 DG2b) can be computed using molec-
ular dynamics (MD) simulations, and is indicated
DDG(calc) (calculated). This difference in free energy
must then be corrected for the free energy that is
required to transfer a proton from TIM to species F, to
yield the relative affinity for species C, DDG(pred). This
correction is given by the difference DG1a 2 DG2a in Fig-
ure 1 and was estimated from the pKs of the deprotona-
tion reactions of the inhibitors in solution [pK1a and
pK2a for PGA and 3PP, respectively; Eqs. (14), (15), (19),
and (20) in the Methods section]. Values of 5.1 and 6.9
were obtained for pK1a and pK2a, respectively (pK2 in
Fig. 2), corresponding to a relative free energy difference
of 210.3 kJ mol21 for DG1a 2 DG2a (Table I). The free
energy difference for the deprotonation of species C of
PGA in solution was therefore more favorable than that
of 3PP. The protonation of the catalytic glutamic acid of
the free enzyme TIM also occurs during processes DG1a
and DG2a (TIM?TIM-H in Fig. 1). However, this contri-
bution is the same in DG1a and DG2a and therefore effec-
tively cancels when the difference is considered.
To estimate pK1a and pK2a, experimental pKa values
(Table III) and ab initio pK calculations (Table IV) were
combined. Note that we use the more generic connota-
tion pK to indicate computational estimates of pKas. In
Figure 2, the final pK values can be read next to the cor-
responding deprotonation reactions. Also the experimen-
tal pKas are shown in Figure 2. If on a molecule there are
multiple protonatable sites, as in the case of PGA and
3PP, the experimental estimate of a pKa cannot be
assigned to a particular (de)protonation reaction in a
straightforward manner. In the following it is discussed
how the experimental pKas were interpreted in view of
the deprotonation reactions in Figure 2. PGA and 3PP
have both three titratable sites and the experimental pKa
values are indicated in Table III as pKaI, pKaII, and
pKaIII. If one compares these values to the standard pKa
values of phosphoric acid (2.1, 7.2, and 12.7), phos-
phonic acid (2.0 and 6.7) and carboxylic group of aspar-
tic acid (3.9) in aqueous solution,36,37 to a first approxi-
mation pKaI and pKaIII can be assigned to the deproto-
nation reaction of the first and second proton of the
phosphate and phosphonomethyl moiety of PGA and
3PP, respectively, and pKaII to the deprotonation of the
carboxylic group of the inhibitor. This last assignment is
consistent with the observation that pKaIII of a phospho-
nate is about 1 pKa unit higher than that of the corre-
sponding phosphate ester.38,39 However, because in so-
lution different ionized forms of the inhibitor coexist,
pKaI, for example, can be associated with two reactions:
deprotonation of the first proton of the phosphate/phos-
phonate group when the carboxylic group at the opposite
end of the molecule is (a) protonated and (b) deproto-
nated, that is, reactions A?B and D?E in Figure 2. As
a consequence pKaI cannot be assigned to a specific reac-
tion, either A?B or D?E. Nevertheless one can consider
that the pKa of a carboxylic group is 3.9 and at a pH cor-
responding to pKaI (about 2), the concentration of a pro-
tonated carboxylic group (as in species A) is almost 80
times larger than that of the deprotonated one (as in spe-
cies D). As the measured pKa will be dominated by the
most abundant species, the pK of reaction A?B, during
which the carboxylic group remains protonated, was
approximated by the measured pKaI. Based on similar
arguments, the pKs of reactions B?E (pK1 in Fig. 2)
and E?F (pK4 in Fig. 2) were assigned to the experi-
mental values of pKaII and pKaIII, respectively. One can
also now see that pK2, the pK of interest for the deproto-
nation reaction of the binding form C to F of the inhibi-
tors, cannot be estimated from such considerations. For
this reason ab initio calculations were used to estimate
its value.
From the estimated pKs in Figure 2, one can observe
the increase of the pK value of a certain deprotonation
reaction when the molecule carries one additional nega-
tive charge (1.5 and 2.3 pKa units for PGA and 3PP,
respectively): compare in this respect reactions 1 with 2
and 3 with 4 in Figure 2. As expected, the higher the
negative charge on the molecule, the lower the tendency
to lose a proton.
It remains now to estimate DDG(calc), the relative af-
finity of the bound form F of the inhibitors for TIM.
DDG(calc) can be obtained from the difference DG3 2
DG4 (Fig. 1 and Eq. (16) in the Methods section). Recall
that DDG(calc) 5 DG1b 2 DG2b 5 DG3 2 DG4 in Figure
1. DG3 and DG4 are the free energy differences between
the F species of the inhibitors in solution and in the
active site of the enzyme, respectively, and were com-
puted using molecular dynamics (MD) simulations and
the thermodynamic integration formula. The calculated
DG3 and DG4 were both positive and of comparable
magnitude, 28.3  4.3 kJ mol21 and 24.1  7.2 kJ mol21,
Table IV
Ab Initio pKs for the Deprotonation Reactions of PGA and 3PP in
Solution at pH 5 7.6
pK1 pK2 pK3 pK4
Ligand B ? E C ? F B ? C E ? F DpK221 DpK324
PGA 23.3 24.8 30.5 32.1 1.5 21.6
3PP 25.2 27.5 35.0 37.4 2.3 22.4
DpK221 and DpK324 together with the experimental pKa values (Table III) are
used to estimate pK2 and pK3 as described in the Methods [Eqs. (19) and (20)].
The differently protonated forms of PGA and 3PP are indicated with letters
according to Figure 2.
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respectively. DDG(calc) was, therefore, not significant
(4.2  8.4 kJ mol21). This indicates that the fully deproto-
nated F species of PGA and 3PP have a comparable affinity
for TIM.
To test for convergence, the reverse transformations
associated with DG3 and DG4 were also calculated. The
results for the reverse transformations were comparable
(within error) to the forward transformations (DG3 5
27.3  4.6 kJ mol21 and DG4 5 19.89.5 kJ mol21),
suggesting that the computed free energies have con-
verged. qH/qk profiles as a function of the coupling pa-
rameter k are shown in Figure 4 for both the reverse and
forward transformations.
DG3 and DG4 were decomposed in contributions cor-
responding to specific bonded and nonbonded interac-
tions (Table V). Although this decomposition has little
physical meaning because the individual components are
not state functions and are therefore dependent on the
path along which the transformation occurs, the analysis provides an indication of the relative importance of dif-
ferent terms within the force field. As can be seen in
Table V, the contributions to the relative free energy
difference from the inhibitor-inhibitor (I-I), inhibitor-
solvent (I-H2O), and inhibitor-enzyme (I-TIM) interac-
tions were 22.0, 10.1, and 23.9 kJ mol21, respectively.
Intramolecular interactions of the inhibitors (I-I) and
interactions of the inhibitors in the active site with TIM
(I-TIM) contributed relatively little to DDG(calc). In par-
ticular, the contribution of the phosphate/phosphono-
methyl of the inhibitor (26.2 kJ mol21) indicates that
the phosphate group is more stable in the active site of
TIM with respect to the phosphonomethyl group.
We have now obtained a DDG(calc) (difference in
affinity of species F of PGA and 3PP for TIM) of 4.2 kJ
mol21 and a difference DG1a 2 DG2a of 210.3 kJ mol
21.
This yields a DDG(pred) (difference in affinity of species
C of PGA and 3PP for TIM) of 26.1 kJ mol21. This
quantity can directly be compared to the DDG(eff) of
225.2 kJ mol21 estimated above [Eq. (21)]. DDG(pred)
is almost 20 kJ mol21 smaller than the effective relative
affinity. Table I summarizes the experimentally measured
and calculated affinities, as well as the measured affinities
for the natural substrates of TIM. The calculated affin-
ities for species F (DDG(calc) — derived from molecular
dynamics and thermodynamic integration) and the pre-
dicted affinities as determined for species C of PGA and
3PP are given separately.
DISCUSSION
Effective affinity
In this work we have introduced the concept of effec-
tive affinity. The effective affinity must be considered in
cases where the inhibitor can exist in alternative protona-
tion states when free in solution and where the dominant
species in solution differs from the species bound to the
Figure 4
hqH/qki (in kJ mol21) as a function of k for the transformation of
the fully deprotonated PGA into 3PP in water (upper panel) and in the
solvated active site of TIM (lower panel). Forward and reverse
transformation are reported in black and gray, respectively.
Table V
Decomposition of DG3, DG4, and DDG(calc) (DG3 2 DG4) in





in TIM 1 H2O
DG3 DG4 DDG
I-I 52.4 54.4 22.0
I-H2O 224.0 234.1 10.1
I-TIM — 3.9 23.9
(COO2)-H2O 11.1 0.9 10.2
(COO2)-TIM — 22.3 2.3
(O/CH2-PO322)-H2O 234.8 234.7 20.1
(O/CH2-PO322)-TIM — 6.2 26.2
The inhibitor contributions I-H2O and I-TIM are furthermore decomposed
between the carboxylic (COO2) and phosphate/phosphonomethyl (O/CH2-
PO322) moieties.
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enzyme. Because experimental affinities are generally
based on the total concentration of inhibitor, the proto-
nation equilibria of the inhibitors in solution make a
contribution to the measured affinity. This implies that
experimental affinities cannot be directly compared with
calculated values, unless one corrects for nonbinding spe-
cies. The difference between the effective and measured
affinities depends on the ratio of the concentration of the
binding form of the ligand with respect to the total con-
centration [Eq. (2)]. If this ratio approaches one, effec-
tive affinities coincide with the measured ones. In the
case of the TIM inhibitors PGA and 3PP, the binding
species is just a small fraction of the total inhibitor con-
centration in solution. The effective affinities of the bind-
ing species of PGA and 3PP for TIM increased by 214.6
and 26.5 kJ mol21, respectively, with respect to the
measured values (Table I). Ignoring the various protona-
tion equilibria and focusing on just the binding species
would lead to an overestimation of the predicted binding
affinity to TIM. An effective affinity therefore allows for
a proper interpretation of experimental affinities and a
direct comparison of calculated and measured affinities.
Predicted relative affinity
Although the preceding discussion shows that the cal-
culations overestimate the experimental binding affinity,
from Table I it is observed that the predicted relative af-
finity DDG(pred) in fact significantly underestimates the
experimental one. There are a number of possible reasons
for this difference.
The first is related to the calculation of DG4, the differ-
ence in the free energy of the bound form of the inhibi-
tors in the active site of the enzyme TIM (Fig. 1). DG4 is
used to calculate DDG(calc). Upon ligand binding, one
of the active site loops of TIM (loop 6) undergoes a large
conformational change as the tip of this loop moves by
about 8 A˚ to close off the active site from bulk sol-
vent.40–42 To avoid sampling changes in the conforma-
tion of loop 6, all heavy atoms of TIM were restrained to
the positions of the PGA-TIM complex during the calcu-
lations. This implies that during the calculation of DG4,
only the closed bound conformation (of the PGA-TIM
complex) is sampled. The free energies associated with
the restraining of the active site containing PGA and 3PP
were not computed as it was assumed that they were of
comparable magnitude. It is reasonable to assume that
the closed conformation is dominant in the bound state
and the two complexes PGA-TIM and 3PP-TIM show a
practically identical mode of binding (Fig. 5). In particu-
lar, the root mean square deviation (RMSD) between the
structures of the two complexes was 0.04 nm for back-
bone atoms and 0.08 nm for active site atoms in a sphere
of 0.4 nm around the inhibitor (Fig. 5). Nevertheless,
this is obviously a source of error.
The second potential source of error is related to the
accuracy of the pK calculations. We applied the B3LYP/6-
31G* level of theory in the ab initio calculations—a com-
promise between accuracy and computational effort—
and found that the calculated absolute pK values were far
off the experimental values (Table IV). The use of relative
differences of the calculated pKs together with the experi-
mentally measured pKas will reduce systematic errors in the
computations. The residual error might still be as large as
1–2 pKunit per calculated pK (6–12 kJ mol21).
Figure 5
(A): Active site scheme of PGA-TIM and 3PP-TIM as observed in the
X-ray structures 1N5526 and 1IIG8, respectively. The bridging oxygen
of PGA is replaced by a CH2 in 3PP (indicated as (C)). All hydrogen
bonds between inhibitor and enzyme atoms and other important
hydrogen bonds are highlighted. Distances in 1N55 and 1IIG (in
parenthesis) are in A˚. TIM is a dimer consisting of two identical
subunits of 250 residues. Thr75* is in loop 3 of the adjacent subunit.
Figure adapted from Kursula and Wiererga.26 (B): Active site X-ray
structures of PGA-TIM (1N55)26, in dark gray, and 3PP-TIM (1IIG)8,
in light gray, superimposed on the backbone atoms of subunits B.
Inhibitors are drawn with thicker bonds (in the center). Catalytic
residues are indicated. Figure generated with Molscript.43
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The relative affinity of the two inhibitors for TIM was
obtained by adding together free energy differences (DG)
from ab initio calculations and molecular dynamics sim-
ulations. The first relies upon a continuum solvation
model for the solvent while for the second a discrete sol-
vation model was employed. Because we are interested in
relative free energy differences, the quantities that were
summed were DDGs (DG1a 2 DG2a and DG3 2 DG4),
rather than DGs. Consequently, systematic errors intro-
duced by each model are expected to cancel.
Another potential source of error is concerned with
the importance of the low barrier hydrogen bond
(LBHB)44 for the binding free energy of TIM. In the
atomic resolution structure of the PGA-TIM complex
one such very strong hydrogen bond between the inhibi-
tor and the enzyme was identified.26 While this work
assumes that this interaction is equally important for
PGA and 3PP, its actual contribution to the affinity dif-
ference of PGA and 3PP for TIM is not clear. Even
though not trivial, a mixed quantum mechanical/molecu-
lar mechanical approach to model this interaction might
be helpful in elucidating this particular aspect.
Despite the above mentioned uncertainties, some qual-
itative conclusions can be drawn from the results. The
reactions considered involve the binding of two inhibi-
tors, PGA and its phosphonate analog 3PP to the glyco-
lytic enzyme TIM. While it is known that phosphonate
analogs of TIM ligands bind more weakly to the enzyme,
the physical basis of this difference is not fully under-
stood.11,38,45 As can be seen in Figure 6, upon binding
the torsion involving the carboxylic group of 3PP
changes from staggered to eclipsed. It has been specu-
lated that this deformation may influence the strength of
ligand binding.8,38,45 This work shows that the energetic
cost of this deformation is in fact rather small (about
2 kJ mol21, Table V) and therefore cannot account for
the observed difference in affinity. Also the contribution
of the inhibitor-enzyme interactions to DDG(pred) was
small (23.9 kJ mol21, Table V), in agreement with the
similarity of the bound PGA-TIM and 3PP-TIM struc-
tures. Instead, the main contribution to the predicted
binding free energy difference was due to the difference
in the pKs of the carboxylic group of the inhibitors in
solution (210.3 kJ mol21, DG1a 2 DG2a, Table I and
Fig. 1). These results underline the importance of consid-
ering the appropriate thermodynamic cycle for free
energy calculations, especially in cases where properties
of the ligand in the bound state differ from that free in
solution. Such considerations are frequently ignored in
computational drug design.47,48
CONCLUSIONS
The contribution of the protonation equilibria of PGA
and 3PP to the binding affinity has been estimated,
which can be used to obtain what we refer to as the
effective affinity of the inhibitor for TIM by subtracting
this correction from the experimental value. The binding
species of PGA effectively binds about 8 kJ mol21 stron-
ger to TIM than the binding species of 3PP, with respect
to the experimental affinity difference. This correction is
required because of the relatively low concentration of
the binding form of PGA in solution as compared to the
binding form of 3PP at the pH used experimentally. By
incorporating this correction it is possible to directly
compare the predicted affinity difference of PGA and
3PP for TIM with the effective affinity difference, as both
refer to the form of the inhibitor that is actually recog-
nized by the enzyme. In this particular case, the theoreti-
cal prediction of the affinity difference of 26.1 kJ mol21
Figure 6
Superimposition of (A) the unbound structures of PGA (yellow) and
3PP (green) (from vacuum calculations) and (B) the bound structures
in the active site of TIM (from the X-ray structures PGA-TIM (PDB
code 1N55)26 and 3PP-TIM (PDB code 1IIG)8). In (B), the active sites
atoms of TIM (defined as a sphere of radius 0.4 nm centered at the
inhibitor) were superimposed. Only the backbone atoms of PGA-TIM
(purple) and the catalytic glutamic acid (Glu 167; oxygen, carbon and
nitrogen atoms colored in red, black, and blue, respectively) are shown.
The inhibitors are drawn with the phosphate/phosphonomethyl moiety
on the left side and the carboxylic group on the right side of the reader.
Figures generated with Molscript43 and Raster3-D.46
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between PGA and 3PP for TIM underestimates the effec-
tive affinity difference of 225.2 kJ mol21 by about 20 kJ
mol21. A failure to properly account for the effect of
ionization could lead to theoretical estimates of free ener-
gies closer to experimental values than in reality. This
underpins the importance to include ligand (solvation)
properties in predictions of affinities for proteins.
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